![Scott Gangloff](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Scott A. Gangloff worked at Incyte Corp.
from 2017 to 2024 as VP-Global Biopharmaceutical Development.
Mr. Gangloff worked at Akero Therapeutics, Inc. from 2024 to 2025 as Chief Technical Officer.
Mr. Gangloff graduated from Lehigh University.
Precedenti posizioni note di Scott Gangloff
| Società | Posizione | Fine |
|---|---|---|
| AKERO THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 09/12/2025 |
| INCYTE CORPORATION | Corporate Officer/Principal | 01/04/2024 |
Formazione di Scott Gangloff
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
13
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Lehigh University
 Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akero Therapeutics, Inc.
 Akero Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for patients with metabolic diseases | Health Technology |
